Literature DB >> 18815035

Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita.

Doreen Fialho1, Dimitri M Kullmann, Michael G Hanna, Stephanie Schorge.   

Abstract

Myotonia congenita is caused by mutations in the voltage-gated chloride channel ClC-1. It is more severe in men than women and often worsens during pregnancy, but the basis for these gender differences is not known. We show here that both testosterone and progesterone rapidly and reversibly inhibit wild-type ClC-1 channels expressed in Xenopus oocytes by causing a prominent rightward shift in the voltage dependence of their open probability. In contrast, 17beta-estradiol at similar concentrations causes only a small shift. Progesterone and testosterone also profoundly inhibit ClC-1 channels containing the mutation F297S associated with dominantly inherited myotonia congenita. The effects of sex hormones are likely to be non-genomic because of their speed of onset and reversibility. These results suggest a possible mechanism to explain how the severity of myotonia congenita can be modulated by sex hormones.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815035     DOI: 10.1016/j.nmd.2008.07.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay.

Authors:  Gianna Ulzi; Valeria A Sansone; Francesca Magri; Stefania Corti; Nereo Bresolin; Giacomo P Comi; Sabrina Lucchiari
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

Review 2.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

3.  Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.

Authors:  Seth Sweetser; Irene A Busciglio; Michael Camilleri; Adil E Bharucha; Lawrence A Szarka; Athanasios Papathanasopoulos; Duane D Burton; Deborah J Eckert; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

Review 4.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

5.  Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutations.

Authors:  Hong-Fu Li; Wan-Jin Chen; Wang Ni; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2014-09-05       Impact factor: 5.203

Review 6.  Physiology and pathophysiology of CLC-1: mechanisms of a chloride channel disease, myotonia.

Authors:  Chih-Yung Tang; Tsung-Yu Chen
Journal:  J Biomed Biotechnol       Date:  2011-12-01

7.  Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita.

Authors:  In-Soo Moon; Hyang-Sook Kim; Jin-Hong Shin; Yeong-Eun Park; Kyu-Hyun Park; Yong-Bum Shin; Jong Seok Bae; Young-Chul Choi; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

8.  Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Authors:  Jaya R Trivedi; Brian Bundy; Jeffrey Statland; Mohammad Salajegheh; Dipa Raja Rayan; Shannon L Venance; Yunxia Wang; Doreen Fialho; Emma Matthews; James Cleland; Nina Gorham; Laura Herbelin; Stephen Cannon; Anthony Amato; Robert C Griggs; Michael G Hanna; Richard J Barohn
Journal:  Brain       Date:  2013-06-13       Impact factor: 13.501

9.  Impaired surface membrane insertion of homo- and heterodimeric human muscle chloride channels carrying amino-terminal myotonia-causing mutations.

Authors:  Katharina Ronstedt; Damien Sternberg; Silvia Detro-Dassen; Thomas Gramkow; Birgit Begemann; Toni Becher; Petra Kilian; Matthias Grieschat; Jan-Philipp Machtens; Günther Schmalzing; Martin Fischer; Christoph Fahlke
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

10.  Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.

Authors:  Celine Dogan; Marie De Antonio; Dalil Hamroun; Hugo Varet; Marianne Fabbro; Felix Rougier; Khadija Amarof; Marie-Christine Arne Bes; Anne-Laure Bedat-Millet; Anthony Behin; Remi Bellance; Françoise Bouhour; Celia Boutte; François Boyer; Emmanuelle Campana-Salort; Françoise Chapon; Pascal Cintas; Claude Desnuelle; Romain Deschamps; Valerie Drouin-Garraud; Xavier Ferrer; Helene Gervais-Bernard; Karima Ghorab; Pascal Laforet; Armelle Magot; Laurent Magy; Dominique Menard; Marie-Christine Minot; Aleksandra Nadaj-Pakleza; Sybille Pellieux; Yann Pereon; Marguerite Preudhomme; Jean Pouget; Sabrina Sacconi; Guilhem Sole; Tanya Stojkovich; Vincent Tiffreau; Andoni Urtizberea; Christophe Vial; Fabien Zagnoli; Gilbert Caranhac; Claude Bourlier; Gerard Riviere; Alain Geille; Romain K Gherardi; Bruno Eymard; Jack Puymirat; Sandrine Katsahian; Guillaume Bassez
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.